Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Natriumklorid Fresenius Kabi
DRUG
2 trials
Sponsors
Lipigon Pharmaceuticals AB
, AstraZeneca AB
Conditions
Heart failure with reduced ejection fraction
Moderate to severe hypertriglyceridemia
Renal impairment
Phase 1
A Phase 1b, Double-blind, Placebo-controlled, Randomised Trial Investigating the Effect of AZD3427 on Renal Perfusion in HFrEF Patients With Renal Impairment Using Positron Emission Tomography (PET)
Completed
CTIS2024-513143-82-00
AstraZeneca AB
Heart failure with reduced ejection fraction, Renal impairment
Start: 2024-10-15
End: 2025-08-21
Target: 12
Updated: 2025-02-11
Phase 2
A phase 2, randomised, double-blind, placebo-controlled trial to evaluate safety and local tolerability of four weekly administrations of A24110He in subjects with elevated triglyceride plasma concentrations
Completed
CTIS2023-509091-42-00
Lipigon Pharmaceuticals AB
Moderate to severe hypertriglyceridemia
Start: 2024-02-27
End: 2026-01-08
Target: 26
Updated: 2025-07-04